FIELD: pharmaceutics.
SUBSTANCE: the present innovation deals with cryoprotective preparations that contain recombinant interferon-α2. The suggested cryoprotective preparation contains recombinant interferon-α2, polyethylene glycol 3000-6000, polyglucin, buffered 0.02%-Trilon B solution at pH being 5.5-7.0 and glycerol at certain ratio of components per 1.0 g preparation. The suggested cryoprotective preparation can additionally contain glycine, 3,7-bis(dimethylamino)phenothiazonium chloride, dry immunoglobulin preparation or dry immunoglobulin preparation for enteral intake. The present innovation provides maximal keeping the activity of recombinant interferon-α2 in cryoprotective preparation at multiple alteration of positive and negative environmental temperature and during storing this cryoprotective preparation under these conditions.
EFFECT: higher efficiency of application.
4 cl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
CRYOPROTECTIVE OINTMENT | 2004 |
|
RU2251430C1 |
AGENT IMPROVING SEMEN QUALITY | 2005 |
|
RU2292908C1 |
COMPOSITION ELICITING ANTIVIRAL EFFECT | 2004 |
|
RU2247576C1 |
COMPOSITION POSSESSING ANTIVIRAL AND ANTIBACTERIAL EFFECT | 2006 |
|
RU2292907C1 |
ANTIVIRAL AND ANTIMICROBIAL COMPOSITION | 2008 |
|
RU2457855C2 |
COMPOSITION ELICITING ANTIBACTERIAL EFFECT | 2004 |
|
RU2247578C1 |
BIOLOGICALLY ACTIVE ADDITION | 2000 |
|
RU2164765C1 |
ANTIVIRAL AND ANTIMICROBIAL COMPOSITION | 2008 |
|
RU2457857C2 |
ANTIVIRAL AND ANTIMICROBIAL ORAL COMPOSITION | 2008 |
|
RU2457856C2 |
METHOD OF TREATING CHRONIC PAIN SYNDROME | 2014 |
|
RU2545915C1 |
Authors
Dates
2005-05-10—Published
2004-04-27—Filed